0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rosuvastatin Intermediates Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-35K18892
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Rosuvastatin Intermediates Market Research Report 2025
BUY CHAPTERS

Global Rosuvastatin Intermediates Market Research Report 2025

Code: QYRE-Auto-35K18892
Report
February 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rosuvastatin Intermediates Market Size

The global market for Rosuvastatin Intermediates was valued at US$ 3086 million in the year 2024 and is projected to reach a revised size of US$ 5053 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Rosuvastatin Intermediates Market

Rosuvastatin Intermediates Market

Rosuvastatin intermediate is one of the key raw materials for the synthesis of rosuvastatin. Rosuvastatin belongs to the statin class of drugs, which is used to lower blood lipids, especially cholesterol levels, and help prevent and treat cardiovascular diseases such as arteriosclerosis and coronary heart disease. As an HMG-CoA reductase inhibitor, rosuvastatin can effectively lower low-density lipoprotein cholesterol in the body.
North American market for Rosuvastatin Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rosuvastatin Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rosuvastatin Intermediates include Manus Aktteva Biopharma, Chemos, Teva Pharmaceutical Industries, MSN Laboratories, Ortin Laboratories, PGShah & Co, VIVAN Life Sciences, Cadila Pharmaceuticals, Nenter & Co., Inc, Yuchen Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rosuvastatin Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin Intermediates.
The Rosuvastatin Intermediates market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rosuvastatin Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rosuvastatin Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rosuvastatin Intermediates Market Report

Report Metric Details
Report Name Rosuvastatin Intermediates Market
Accounted market size in year US$ 3086 million
Forecasted market size in 2031 US$ 5053 million
CAGR 7.3%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Alcohols
  • Amines
  • Others
by Application
  • Pharmaceuticals
  • Scientific Research
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Manus Aktteva Biopharma, Chemos, Teva Pharmaceutical Industries, MSN Laboratories, Ortin Laboratories, PGShah & Co, VIVAN Life Sciences, Cadila Pharmaceuticals, Nenter & Co., Inc, Yuchen Pharmaceutical, Lepu Medical Technology, Hongyuan Pharmaceutical, Aifeimu Technology, Ninhua Group, Fengjin Pharmaceutical, Alpha Pharmaceutical, Yongtai Technology, Xinrui Pharmaceutical, Yitai Pharmaceutical, Yutian Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rosuvastatin Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Rosuvastatin Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Rosuvastatin Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Rosuvastatin Intermediates Market growing?

Ans: The Rosuvastatin Intermediates Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Rosuvastatin Intermediates Market size in 2031?

Ans: The Rosuvastatin Intermediates Market size in 2031 will be US$ 5053 million.

Who are the main players in the Rosuvastatin Intermediates Market report?

Ans: The main players in the Rosuvastatin Intermediates Market are Manus Aktteva Biopharma, Chemos, Teva Pharmaceutical Industries, MSN Laboratories, Ortin Laboratories, PGShah & Co, VIVAN Life Sciences, Cadila Pharmaceuticals, Nenter & Co., Inc, Yuchen Pharmaceutical, Lepu Medical Technology, Hongyuan Pharmaceutical, Aifeimu Technology, Ninhua Group, Fengjin Pharmaceutical, Alpha Pharmaceutical, Yongtai Technology, Xinrui Pharmaceutical, Yitai Pharmaceutical, Yutian Pharmaceutical

What are the Application segmentation covered in the Rosuvastatin Intermediates Market report?

Ans: The Applications covered in the Rosuvastatin Intermediates Market report are Pharmaceuticals, Scientific Research, Others

What are the Type segmentation covered in the Rosuvastatin Intermediates Market report?

Ans: The Types covered in the Rosuvastatin Intermediates Market report are Alcohols, Amines, Others

1 Rosuvastatin Intermediates Market Overview
1.1 Product Definition
1.2 Rosuvastatin Intermediates by Type
1.2.1 Global Rosuvastatin Intermediates Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Alcohols
1.2.3 Amines
1.2.4 Others
1.3 Rosuvastatin Intermediates by Application
1.3.1 Global Rosuvastatin Intermediates Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Rosuvastatin Intermediates Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Rosuvastatin Intermediates Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Rosuvastatin Intermediates Production Estimates and Forecasts (2020-2031)
1.4.4 Global Rosuvastatin Intermediates Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Rosuvastatin Intermediates Production Market Share by Manufacturers (2020-2025)
2.2 Global Rosuvastatin Intermediates Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Rosuvastatin Intermediates, Industry Ranking, 2023 VS 2024
2.4 Global Rosuvastatin Intermediates Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Rosuvastatin Intermediates Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Rosuvastatin Intermediates, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Rosuvastatin Intermediates, Product Offered and Application
2.8 Global Key Manufacturers of Rosuvastatin Intermediates, Date of Enter into This Industry
2.9 Rosuvastatin Intermediates Market Competitive Situation and Trends
2.9.1 Rosuvastatin Intermediates Market Concentration Rate
2.9.2 Global 5 and 10 Largest Rosuvastatin Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Rosuvastatin Intermediates Production by Region
3.1 Global Rosuvastatin Intermediates Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Rosuvastatin Intermediates Production Value by Region (2020-2031)
3.2.1 Global Rosuvastatin Intermediates Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Rosuvastatin Intermediates by Region (2026-2031)
3.3 Global Rosuvastatin Intermediates Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Rosuvastatin Intermediates Production Volume by Region (2020-2031)
3.4.1 Global Rosuvastatin Intermediates Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Rosuvastatin Intermediates by Region (2026-2031)
3.5 Global Rosuvastatin Intermediates Market Price Analysis by Region (2020-2025)
3.6 Global Rosuvastatin Intermediates Production and Value, Year-over-Year Growth
3.6.1 North America Rosuvastatin Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Rosuvastatin Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Rosuvastatin Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Rosuvastatin Intermediates Production Value Estimates and Forecasts (2020-2031)
4 Rosuvastatin Intermediates Consumption by Region
4.1 Global Rosuvastatin Intermediates Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Rosuvastatin Intermediates Consumption by Region (2020-2031)
4.2.1 Global Rosuvastatin Intermediates Consumption by Region (2020-2025)
4.2.2 Global Rosuvastatin Intermediates Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Rosuvastatin Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Rosuvastatin Intermediates Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Rosuvastatin Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Rosuvastatin Intermediates Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Rosuvastatin Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Rosuvastatin Intermediates Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Rosuvastatin Intermediates Production by Type (2020-2031)
5.1.1 Global Rosuvastatin Intermediates Production by Type (2020-2025)
5.1.2 Global Rosuvastatin Intermediates Production by Type (2026-2031)
5.1.3 Global Rosuvastatin Intermediates Production Market Share by Type (2020-2031)
5.2 Global Rosuvastatin Intermediates Production Value by Type (2020-2031)
5.2.1 Global Rosuvastatin Intermediates Production Value by Type (2020-2025)
5.2.2 Global Rosuvastatin Intermediates Production Value by Type (2026-2031)
5.2.3 Global Rosuvastatin Intermediates Production Value Market Share by Type (2020-2031)
5.3 Global Rosuvastatin Intermediates Price by Type (2020-2031)
6 Segment by Application
6.1 Global Rosuvastatin Intermediates Production by Application (2020-2031)
6.1.1 Global Rosuvastatin Intermediates Production by Application (2020-2025)
6.1.2 Global Rosuvastatin Intermediates Production by Application (2026-2031)
6.1.3 Global Rosuvastatin Intermediates Production Market Share by Application (2020-2031)
6.2 Global Rosuvastatin Intermediates Production Value by Application (2020-2031)
6.2.1 Global Rosuvastatin Intermediates Production Value by Application (2020-2025)
6.2.2 Global Rosuvastatin Intermediates Production Value by Application (2026-2031)
6.2.3 Global Rosuvastatin Intermediates Production Value Market Share by Application (2020-2031)
6.3 Global Rosuvastatin Intermediates Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Manus Aktteva Biopharma
7.1.1 Manus Aktteva Biopharma Rosuvastatin Intermediates Company Information
7.1.2 Manus Aktteva Biopharma Rosuvastatin Intermediates Product Portfolio
7.1.3 Manus Aktteva Biopharma Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Manus Aktteva Biopharma Main Business and Markets Served
7.1.5 Manus Aktteva Biopharma Recent Developments/Updates
7.2 Chemos
7.2.1 Chemos Rosuvastatin Intermediates Company Information
7.2.2 Chemos Rosuvastatin Intermediates Product Portfolio
7.2.3 Chemos Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Chemos Main Business and Markets Served
7.2.5 Chemos Recent Developments/Updates
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Rosuvastatin Intermediates Company Information
7.3.2 Teva Pharmaceutical Industries Rosuvastatin Intermediates Product Portfolio
7.3.3 Teva Pharmaceutical Industries Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Teva Pharmaceutical Industries Main Business and Markets Served
7.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.4 MSN Laboratories
7.4.1 MSN Laboratories Rosuvastatin Intermediates Company Information
7.4.2 MSN Laboratories Rosuvastatin Intermediates Product Portfolio
7.4.3 MSN Laboratories Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.4.4 MSN Laboratories Main Business and Markets Served
7.4.5 MSN Laboratories Recent Developments/Updates
7.5 Ortin Laboratories
7.5.1 Ortin Laboratories Rosuvastatin Intermediates Company Information
7.5.2 Ortin Laboratories Rosuvastatin Intermediates Product Portfolio
7.5.3 Ortin Laboratories Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Ortin Laboratories Main Business and Markets Served
7.5.5 Ortin Laboratories Recent Developments/Updates
7.6 PGShah & Co
7.6.1 PGShah & Co Rosuvastatin Intermediates Company Information
7.6.2 PGShah & Co Rosuvastatin Intermediates Product Portfolio
7.6.3 PGShah & Co Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.6.4 PGShah & Co Main Business and Markets Served
7.6.5 PGShah & Co Recent Developments/Updates
7.7 VIVAN Life Sciences
7.7.1 VIVAN Life Sciences Rosuvastatin Intermediates Company Information
7.7.2 VIVAN Life Sciences Rosuvastatin Intermediates Product Portfolio
7.7.3 VIVAN Life Sciences Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.7.4 VIVAN Life Sciences Main Business and Markets Served
7.7.5 VIVAN Life Sciences Recent Developments/Updates
7.8 Cadila Pharmaceuticals
7.8.1 Cadila Pharmaceuticals Rosuvastatin Intermediates Company Information
7.8.2 Cadila Pharmaceuticals Rosuvastatin Intermediates Product Portfolio
7.8.3 Cadila Pharmaceuticals Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Cadila Pharmaceuticals Main Business and Markets Served
7.8.5 Cadila Pharmaceuticals Recent Developments/Updates
7.9 Nenter & Co., Inc
7.9.1 Nenter & Co., Inc Rosuvastatin Intermediates Company Information
7.9.2 Nenter & Co., Inc Rosuvastatin Intermediates Product Portfolio
7.9.3 Nenter & Co., Inc Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Nenter & Co., Inc Main Business and Markets Served
7.9.5 Nenter & Co., Inc Recent Developments/Updates
7.10 Yuchen Pharmaceutical
7.10.1 Yuchen Pharmaceutical Rosuvastatin Intermediates Company Information
7.10.2 Yuchen Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.10.3 Yuchen Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Yuchen Pharmaceutical Main Business and Markets Served
7.10.5 Yuchen Pharmaceutical Recent Developments/Updates
7.11 Lepu Medical Technology
7.11.1 Lepu Medical Technology Rosuvastatin Intermediates Company Information
7.11.2 Lepu Medical Technology Rosuvastatin Intermediates Product Portfolio
7.11.3 Lepu Medical Technology Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Lepu Medical Technology Main Business and Markets Served
7.11.5 Lepu Medical Technology Recent Developments/Updates
7.12 Hongyuan Pharmaceutical
7.12.1 Hongyuan Pharmaceutical Rosuvastatin Intermediates Company Information
7.12.2 Hongyuan Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.12.3 Hongyuan Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Hongyuan Pharmaceutical Main Business and Markets Served
7.12.5 Hongyuan Pharmaceutical Recent Developments/Updates
7.13 Aifeimu Technology
7.13.1 Aifeimu Technology Rosuvastatin Intermediates Company Information
7.13.2 Aifeimu Technology Rosuvastatin Intermediates Product Portfolio
7.13.3 Aifeimu Technology Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Aifeimu Technology Main Business and Markets Served
7.13.5 Aifeimu Technology Recent Developments/Updates
7.14 Ninhua Group
7.14.1 Ninhua Group Rosuvastatin Intermediates Company Information
7.14.2 Ninhua Group Rosuvastatin Intermediates Product Portfolio
7.14.3 Ninhua Group Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Ninhua Group Main Business and Markets Served
7.14.5 Ninhua Group Recent Developments/Updates
7.15 Fengjin Pharmaceutical
7.15.1 Fengjin Pharmaceutical Rosuvastatin Intermediates Company Information
7.15.2 Fengjin Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.15.3 Fengjin Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Fengjin Pharmaceutical Main Business and Markets Served
7.15.5 Fengjin Pharmaceutical Recent Developments/Updates
7.16 Alpha Pharmaceutical
7.16.1 Alpha Pharmaceutical Rosuvastatin Intermediates Company Information
7.16.2 Alpha Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.16.3 Alpha Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Alpha Pharmaceutical Main Business and Markets Served
7.16.5 Alpha Pharmaceutical Recent Developments/Updates
7.17 Yongtai Technology
7.17.1 Yongtai Technology Rosuvastatin Intermediates Company Information
7.17.2 Yongtai Technology Rosuvastatin Intermediates Product Portfolio
7.17.3 Yongtai Technology Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Yongtai Technology Main Business and Markets Served
7.17.5 Yongtai Technology Recent Developments/Updates
7.18 Xinrui Pharmaceutical
7.18.1 Xinrui Pharmaceutical Rosuvastatin Intermediates Company Information
7.18.2 Xinrui Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.18.3 Xinrui Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Xinrui Pharmaceutical Main Business and Markets Served
7.18.5 Xinrui Pharmaceutical Recent Developments/Updates
7.19 Yitai Pharmaceutical
7.19.1 Yitai Pharmaceutical Rosuvastatin Intermediates Company Information
7.19.2 Yitai Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.19.3 Yitai Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Yitai Pharmaceutical Main Business and Markets Served
7.19.5 Yitai Pharmaceutical Recent Developments/Updates
7.20 Yutian Pharmaceutical
7.20.1 Yutian Pharmaceutical Rosuvastatin Intermediates Company Information
7.20.2 Yutian Pharmaceutical Rosuvastatin Intermediates Product Portfolio
7.20.3 Yutian Pharmaceutical Rosuvastatin Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Yutian Pharmaceutical Main Business and Markets Served
7.20.5 Yutian Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Rosuvastatin Intermediates Industry Chain Analysis
8.2 Rosuvastatin Intermediates Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Rosuvastatin Intermediates Production Mode & Process Analysis
8.4 Rosuvastatin Intermediates Sales and Marketing
8.4.1 Rosuvastatin Intermediates Sales Channels
8.4.2 Rosuvastatin Intermediates Distributors
8.5 Rosuvastatin Intermediates Customer Analysis
9 Rosuvastatin Intermediates Market Dynamics
9.1 Rosuvastatin Intermediates Industry Trends
9.2 Rosuvastatin Intermediates Market Drivers
9.3 Rosuvastatin Intermediates Market Challenges
9.4 Rosuvastatin Intermediates Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Rosuvastatin Intermediates Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Rosuvastatin Intermediates Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Rosuvastatin Intermediates Production Capacity (kg) by Manufacturers in 2024
 Table 4. Global Rosuvastatin Intermediates Production by Manufacturers (2020-2025) & (kg)
 Table 5. Global Rosuvastatin Intermediates Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Rosuvastatin Intermediates Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Rosuvastatin Intermediates Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Rosuvastatin Intermediates, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Rosuvastatin Intermediates as of 2024)
 Table 10. Global Market Rosuvastatin Intermediates Average Price by Manufacturers (US$/g) & (2020-2025)
 Table 11. Global Key Manufacturers of Rosuvastatin Intermediates, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Rosuvastatin Intermediates, Product Offered and Application
 Table 13. Global Key Manufacturers of Rosuvastatin Intermediates, Date of Enter into This Industry
 Table 14. Global Rosuvastatin Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rosuvastatin Intermediates Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Rosuvastatin Intermediates Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Rosuvastatin Intermediates Production Value Market Share by Region (2020-2025)
 Table 19. Global Rosuvastatin Intermediates Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Rosuvastatin Intermediates Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Rosuvastatin Intermediates Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
 Table 22. Global Rosuvastatin Intermediates Production (kg) by Region (2020-2025)
 Table 23. Global Rosuvastatin Intermediates Production Market Share by Region (2020-2025)
 Table 24. Global Rosuvastatin Intermediates Production (kg) Forecast by Region (2026-2031)
 Table 25. Global Rosuvastatin Intermediates Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Rosuvastatin Intermediates Market Average Price (US$/g) by Region (2020-2025)
 Table 27. Global Rosuvastatin Intermediates Market Average Price (US$/g) by Region (2026-2031)
 Table 28. Global Rosuvastatin Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
 Table 29. Global Rosuvastatin Intermediates Consumption by Region (2020-2025) & (kg)
 Table 30. Global Rosuvastatin Intermediates Consumption Market Share by Region (2020-2025)
 Table 31. Global Rosuvastatin Intermediates Forecasted Consumption by Region (2026-2031) & (kg)
 Table 32. Global Rosuvastatin Intermediates Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Rosuvastatin Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 34. North America Rosuvastatin Intermediates Consumption by Country (2020-2025) & (kg)
 Table 35. North America Rosuvastatin Intermediates Consumption by Country (2026-2031) & (kg)
 Table 36. Europe Rosuvastatin Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 37. Europe Rosuvastatin Intermediates Consumption by Country (2020-2025) & (kg)
 Table 38. Europe Rosuvastatin Intermediates Consumption by Country (2026-2031) & (kg)
 Table 39. Asia Pacific Rosuvastatin Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
 Table 40. Asia Pacific Rosuvastatin Intermediates Consumption by Region (2020-2025) & (kg)
 Table 41. Asia Pacific Rosuvastatin Intermediates Consumption by Region (2026-2031) & (kg)
 Table 42. Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 43. Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption by Country (2020-2025) & (kg)
 Table 44. Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption by Country (2026-2031) & (kg)
 Table 45. Global Rosuvastatin Intermediates Production (kg) by Type (2020-2025)
 Table 46. Global Rosuvastatin Intermediates Production (kg) by Type (2026-2031)
 Table 47. Global Rosuvastatin Intermediates Production Market Share by Type (2020-2025)
 Table 48. Global Rosuvastatin Intermediates Production Market Share by Type (2026-2031)
 Table 49. Global Rosuvastatin Intermediates Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Rosuvastatin Intermediates Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Rosuvastatin Intermediates Production Value Market Share by Type (2020-2025)
 Table 52. Global Rosuvastatin Intermediates Production Value Market Share by Type (2026-2031)
 Table 53. Global Rosuvastatin Intermediates Price (US$/g) by Type (2020-2025)
 Table 54. Global Rosuvastatin Intermediates Price (US$/g) by Type (2026-2031)
 Table 55. Global Rosuvastatin Intermediates Production (kg) by Application (2020-2025)
 Table 56. Global Rosuvastatin Intermediates Production (kg) by Application (2026-2031)
 Table 57. Global Rosuvastatin Intermediates Production Market Share by Application (2020-2025)
 Table 58. Global Rosuvastatin Intermediates Production Market Share by Application (2026-2031)
 Table 59. Global Rosuvastatin Intermediates Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Rosuvastatin Intermediates Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Rosuvastatin Intermediates Production Value Market Share by Application (2020-2025)
 Table 62. Global Rosuvastatin Intermediates Production Value Market Share by Application (2026-2031)
 Table 63. Global Rosuvastatin Intermediates Price (US$/g) by Application (2020-2025)
 Table 64. Global Rosuvastatin Intermediates Price (US$/g) by Application (2026-2031)
 Table 65. Manus Aktteva Biopharma Rosuvastatin Intermediates Company Information
 Table 66. Manus Aktteva Biopharma Rosuvastatin Intermediates Specification and Application
 Table 67. Manus Aktteva Biopharma Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 68. Manus Aktteva Biopharma Main Business and Markets Served
 Table 69. Manus Aktteva Biopharma Recent Developments/Updates
 Table 70. Chemos Rosuvastatin Intermediates Company Information
 Table 71. Chemos Rosuvastatin Intermediates Specification and Application
 Table 72. Chemos Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Chemos Main Business and Markets Served
 Table 74. Chemos Recent Developments/Updates
 Table 75. Teva Pharmaceutical Industries Rosuvastatin Intermediates Company Information
 Table 76. Teva Pharmaceutical Industries Rosuvastatin Intermediates Specification and Application
 Table 77. Teva Pharmaceutical Industries Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceutical Industries Main Business and Markets Served
 Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 80. MSN Laboratories Rosuvastatin Intermediates Company Information
 Table 81. MSN Laboratories Rosuvastatin Intermediates Specification and Application
 Table 82. MSN Laboratories Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. MSN Laboratories Main Business and Markets Served
 Table 84. MSN Laboratories Recent Developments/Updates
 Table 85. Ortin Laboratories Rosuvastatin Intermediates Company Information
 Table 86. Ortin Laboratories Rosuvastatin Intermediates Specification and Application
 Table 87. Ortin Laboratories Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. Ortin Laboratories Main Business and Markets Served
 Table 89. Ortin Laboratories Recent Developments/Updates
 Table 90. PGShah & Co Rosuvastatin Intermediates Company Information
 Table 91. PGShah & Co Rosuvastatin Intermediates Specification and Application
 Table 92. PGShah & Co Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. PGShah & Co Main Business and Markets Served
 Table 94. PGShah & Co Recent Developments/Updates
 Table 95. VIVAN Life Sciences Rosuvastatin Intermediates Company Information
 Table 96. VIVAN Life Sciences Rosuvastatin Intermediates Specification and Application
 Table 97. VIVAN Life Sciences Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. VIVAN Life Sciences Main Business and Markets Served
 Table 99. VIVAN Life Sciences Recent Developments/Updates
 Table 100. Cadila Pharmaceuticals Rosuvastatin Intermediates Company Information
 Table 101. Cadila Pharmaceuticals Rosuvastatin Intermediates Specification and Application
 Table 102. Cadila Pharmaceuticals Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. Cadila Pharmaceuticals Main Business and Markets Served
 Table 104. Cadila Pharmaceuticals Recent Developments/Updates
 Table 105. Nenter & Co., Inc Rosuvastatin Intermediates Company Information
 Table 106. Nenter & Co., Inc Rosuvastatin Intermediates Specification and Application
 Table 107. Nenter & Co., Inc Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. Nenter & Co., Inc Main Business and Markets Served
 Table 109. Nenter & Co., Inc Recent Developments/Updates
 Table 110. Yuchen Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 111. Yuchen Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 112. Yuchen Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. Yuchen Pharmaceutical Main Business and Markets Served
 Table 114. Yuchen Pharmaceutical Recent Developments/Updates
 Table 115. Lepu Medical Technology Rosuvastatin Intermediates Company Information
 Table 116. Lepu Medical Technology Rosuvastatin Intermediates Specification and Application
 Table 117. Lepu Medical Technology Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 118. Lepu Medical Technology Main Business and Markets Served
 Table 119. Lepu Medical Technology Recent Developments/Updates
 Table 120. Hongyuan Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 121. Hongyuan Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 122. Hongyuan Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 123. Hongyuan Pharmaceutical Main Business and Markets Served
 Table 124. Hongyuan Pharmaceutical Recent Developments/Updates
 Table 125. Aifeimu Technology Rosuvastatin Intermediates Company Information
 Table 126. Aifeimu Technology Rosuvastatin Intermediates Specification and Application
 Table 127. Aifeimu Technology Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 128. Aifeimu Technology Main Business and Markets Served
 Table 129. Aifeimu Technology Recent Developments/Updates
 Table 130. Ninhua Group Rosuvastatin Intermediates Company Information
 Table 131. Ninhua Group Rosuvastatin Intermediates Specification and Application
 Table 132. Ninhua Group Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 133. Ninhua Group Main Business and Markets Served
 Table 134. Ninhua Group Recent Developments/Updates
 Table 135. Fengjin Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 136. Fengjin Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 137. Fengjin Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 138. Fengjin Pharmaceutical Main Business and Markets Served
 Table 139. Fengjin Pharmaceutical Recent Developments/Updates
 Table 140. Alpha Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 141. Alpha Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 142. Alpha Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 143. Alpha Pharmaceutical Main Business and Markets Served
 Table 144. Alpha Pharmaceutical Recent Developments/Updates
 Table 145. Yongtai Technology Rosuvastatin Intermediates Company Information
 Table 146. Yongtai Technology Rosuvastatin Intermediates Specification and Application
 Table 147. Yongtai Technology Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 148. Yongtai Technology Main Business and Markets Served
 Table 149. Yongtai Technology Recent Developments/Updates
 Table 150. Xinrui Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 151. Xinrui Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 152. Xinrui Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 153. Xinrui Pharmaceutical Main Business and Markets Served
 Table 154. Xinrui Pharmaceutical Recent Developments/Updates
 Table 155. Yitai Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 156. Yitai Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 157. Yitai Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 158. Yitai Pharmaceutical Main Business and Markets Served
 Table 159. Yitai Pharmaceutical Recent Developments/Updates
 Table 160. Yutian Pharmaceutical Rosuvastatin Intermediates Company Information
 Table 161. Yutian Pharmaceutical Rosuvastatin Intermediates Specification and Application
 Table 162. Yutian Pharmaceutical Rosuvastatin Intermediates Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 163. Yutian Pharmaceutical Main Business and Markets Served
 Table 164. Yutian Pharmaceutical Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Rosuvastatin Intermediates Distributors List
 Table 168. Rosuvastatin Intermediates Customers List
 Table 169. Rosuvastatin Intermediates Market Trends
 Table 170. Rosuvastatin Intermediates Market Drivers
 Table 171. Rosuvastatin Intermediates Market Challenges
 Table 172. Rosuvastatin Intermediates Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rosuvastatin Intermediates
 Figure 2. Global Rosuvastatin Intermediates Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Rosuvastatin Intermediates Market Share by Type: 2024 VS 2031
 Figure 4. Alcohols Product Picture
 Figure 5. Amines Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Rosuvastatin Intermediates Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Rosuvastatin Intermediates Market Share by Application: 2024 VS 2031
 Figure 9. Pharmaceuticals
 Figure 10. Scientific Research
 Figure 11. Others
 Figure 12. Global Rosuvastatin Intermediates Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Rosuvastatin Intermediates Production Value (US$ Million) & (2020-2031)
 Figure 14. Global Rosuvastatin Intermediates Production Capacity (kg) & (2020-2031)
 Figure 15. Global Rosuvastatin Intermediates Production (kg) & (2020-2031)
 Figure 16. Global Rosuvastatin Intermediates Average Price (US$/g) & (2020-2031)
 Figure 17. Rosuvastatin Intermediates Report Years Considered
 Figure 18. Rosuvastatin Intermediates Production Share by Manufacturers in 2024
 Figure 19. Global Rosuvastatin Intermediates Production Value Share by Manufacturers (2024)
 Figure 20. Rosuvastatin Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. The Global 5 and 10 Largest Players: Market Share by Rosuvastatin Intermediates Revenue in 2024
 Figure 22. Global Rosuvastatin Intermediates Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 23. Global Rosuvastatin Intermediates Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. Global Rosuvastatin Intermediates Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
 Figure 25. Global Rosuvastatin Intermediates Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. North America Rosuvastatin Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Europe Rosuvastatin Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. China Rosuvastatin Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Japan Rosuvastatin Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Global Rosuvastatin Intermediates Consumption by Region: 2020 VS 2024 VS 2031 (kg)
 Figure 31. Global Rosuvastatin Intermediates Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 32. North America Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 33. North America Rosuvastatin Intermediates Consumption Market Share by Country (2020-2031)
 Figure 34. U.S. Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 35. Canada Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 36. Europe Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 37. Europe Rosuvastatin Intermediates Consumption Market Share by Country (2020-2031)
 Figure 38. Germany Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 39. France Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 40. U.K. Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 41. Italy Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 42. Russia Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 43. Asia Pacific Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 44. Asia Pacific Rosuvastatin Intermediates Consumption Market Share by Region (2020-2031)
 Figure 45. China Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 46. Japan Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 47. South Korea Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 48. China Taiwan Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 49. Southeast Asia Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 50. India Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 51. Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 52. Latin America, Middle East & Africa Rosuvastatin Intermediates Consumption Market Share by Country (2020-2031)
 Figure 53. Mexico Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 54. Brazil Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 55. Turkey Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 56. GCC Countries Rosuvastatin Intermediates Consumption and Growth Rate (2020-2031) & (kg)
 Figure 57. Global Production Market Share of Rosuvastatin Intermediates by Type (2020-2031)
 Figure 58. Global Production Value Market Share of Rosuvastatin Intermediates by Type (2020-2031)
 Figure 59. Global Rosuvastatin Intermediates Price (US$/g) by Type (2020-2031)
 Figure 60. Global Production Market Share of Rosuvastatin Intermediates by Application (2020-2031)
 Figure 61. Global Production Value Market Share of Rosuvastatin Intermediates by Application (2020-2031)
 Figure 62. Global Rosuvastatin Intermediates Price (US$/g) by Application (2020-2031)
 Figure 63. Rosuvastatin Intermediates Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS